EAHAD 2022: HMB-001 A novel bispecific antibody with potential for subcutaneous prophylactic treatment of multiple bleeding disorders initial focus on Glanzmann Thrombasthenia (GT)
Presented at 15th Annual Congress of the European Association of Haemophilia and Allied Disorders
To view the presentation, click here